These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 8690798

  • 1. Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia.
    Lentz SR, Sobey CG, Piegors DJ, Bhopatkar MY, Faraci FM, Malinow MR, Heistad DD.
    J Clin Invest; 1996 Jul 01; 98(1):24-9. PubMed ID: 8690798
    [Abstract] [Full Text] [Related]

  • 2. Consequences of hyperhomocyst(e)inemia on vascular function in atherosclerotic monkeys.
    Lentz SR, Malinow MR, Piegors DJ, Bhopatkar-Teredesai M, Faraci FM, Heistad DD.
    Arterioscler Thromb Vasc Biol; 1997 Nov 01; 17(11):2930-4. PubMed ID: 9409278
    [Abstract] [Full Text] [Related]

  • 3. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia.
    Böger RH, Bode-Böger SM, Sydow K, Heistad DD, Lentz SR.
    Arterioscler Thromb Vasc Biol; 2000 Jun 01; 20(6):1557-64. PubMed ID: 10845872
    [Abstract] [Full Text] [Related]

  • 4. Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease.
    Manns BJ, Burgess ED, Hyndman ME, Parsons HG, Schaefer JP, Scott-Douglas NW.
    Am J Kidney Dis; 1999 Oct 01; 34(4):669-77. PubMed ID: 10516348
    [Abstract] [Full Text] [Related]

  • 5. Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM.
    Hofmann MA, Kohl B, Zumbach MS, Borcea V, Bierhaus A, Henkels M, Amiral J, Fiehn W, Ziegler R, Wahl P, Nawroth PP.
    Diabetes Care; 1997 Dec 01; 20(12):1880-6. PubMed ID: 9405911
    [Abstract] [Full Text] [Related]

  • 6. Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans.
    Tawakol A, Omland T, Gerhard M, Wu JT, Creager MA.
    Circulation; 1997 Mar 04; 95(5):1119-21. PubMed ID: 9054838
    [Abstract] [Full Text] [Related]

  • 7. Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM.
    Hofmann MA, Kohl B, Zumbach MS, Borcea V, Bierhaus A, Henkels M, Amiral J, Schmidt AM, Fiehn W, Ziegler R, Wahl P, Nawroth PP.
    Diabetes Care; 1998 May 04; 21(5):841-8. PubMed ID: 9589252
    [Abstract] [Full Text] [Related]

  • 8. Asymmetric dimethyl-L-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction.
    Stühlinger MC, Stanger O.
    Curr Drug Metab; 2005 Feb 04; 6(1):3-14. PubMed ID: 15720202
    [Abstract] [Full Text] [Related]

  • 9. Vascular dysfunction in hyperhomocyst(e)inemia. Implications for atherothrombotic disease.
    Stanger O, Weger M, Renner W, Konetschny R.
    Clin Chem Lab Med; 2001 Aug 04; 39(8):725-33. PubMed ID: 11592442
    [Abstract] [Full Text] [Related]

  • 10. Impaired anticoagulant response to infusion of thrombin in atherosclerotic monkeys associated with acquired defects in the protein C system.
    Lentz SR, Fernández JA, Griffin JH, Piegors DJ, Erger RA, Malinow MR, Heistad DD.
    Arterioscler Thromb Vasc Biol; 1999 Jul 04; 19(7):1744-50. PubMed ID: 10397693
    [Abstract] [Full Text] [Related]

  • 11. Genetic and nongenetic factors for moderate hyperhomocyst(e)inemia.
    Kang SS, Wong PW.
    Atherosclerosis; 1996 Jan 26; 119(2):135-8. PubMed ID: 8808490
    [Abstract] [Full Text] [Related]

  • 12. Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine.
    Stühlinger MC, Oka RK, Graf EE, Schmölzer I, Upson BM, Kapoor O, Szuba A, Malinow MR, Wascher TC, Pachinger O, Cooke JP.
    Circulation; 2003 Aug 26; 108(8):933-8. PubMed ID: 12912818
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hyperhomocyst(e)inemia in renal transplant recipients with and without cyclosporine.
    Ducloux D, Fournier V, Rebibou JM, Bresson-Vautrin C, Gibey R, Chalopin JM.
    Clin Nephrol; 1998 Apr 26; 49(4):232-5. PubMed ID: 9582553
    [Abstract] [Full Text] [Related]

  • 15. Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans.
    Kanani PM, Sinkey CA, Browning RL, Allaman M, Knapp HR, Haynes WG.
    Circulation; 1999 Sep 14; 100(11):1161-8. PubMed ID: 10484535
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Hyperhomocyst(e)inemia--an independent risk factor of stroke].
    Lalouschek W, Aull S, Deecke L, Schnider P, Uhl F, Zeiler K.
    Fortschr Neurol Psychiatr; 1996 Jul 14; 64(7):271-7. PubMed ID: 8765893
    [Abstract] [Full Text] [Related]

  • 18. Pathogenicity of thermolabile methylenetetrahydrofolate reductase for vascular dementia.
    Yoo JH, Choi GD, Kang SS.
    Arterioscler Thromb Vasc Biol; 2000 Aug 14; 20(8):1921-5. PubMed ID: 10938012
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hyperhomocyst(e)inemia induces multiorgan damage.
    Miller A, Mujumdar V, Shek E, Guillot J, Angelo M, Palmer L, Tyagi SC.
    Heart Vessels; 2000 Aug 14; 15(3):135-43. PubMed ID: 11289502
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.